Cite
HARVARD Citation
Cabioglu, N. et al. (n.d.). Differential expression of novel immunological biomarkers in TILS is associated with improved outcome in advanced triple negative breast cancer resistant to neoadjuvant chemotherapy. Breast. pp. S40-. [Online].